Reveal ctDNA

FusionPlex

Immunoverse

VariantPlex

Archer in the News

  • Archer at 106th Annual Meeting of Japanese Society of Pathology in Tokyo
    Apr 27, 2017

    We'll be co-attending with Illumina at the inaugural Japanese Society of Pathology in Tokyo. We'll be presenting five posters at this event and giving away corresponding poster flyers with the lead scientist contact info for later review. This gathering will strive to establish a focus on diagnosis that is based on an integrated understanding of disease through the use of high-sensitivity, high-volume analytical technologies like next-generation sequencers and embrace the ideal of giving something back to medicine and society as the goal of pathology.


  • Archer presents workshop at Biomarkers and Immuno-Oncology World Congress 2017
    May 2, 2017

    We'll be exhibiting at Cambridge Healthtech Institute’s Thirteenth Annual Biomarkers and Immuno-Oncology World Congress and will presenting a poster and a workshop featuring on B- and T-Cell Immune Repertoire Characterization by Anchored Multiplex PCR and Next-Generation Sequencing. This conference is dedicated to all areas of biomarker research and development spanning the pharmaceutical and diagnostic pipelines.


  • Archer attends the Children's Oncology Group Cytogenetics Workshop 2017
    May 5, 2017

    Archer attends the Children's Oncology Group Cytogenetics Workshop 2017


  • Archer sponsors Breast Cancer research platform
    May 11, 2017

    ArcherDX is partnering with Susan G. Komen Colorado and the University of Colorado Cancer Center to create a local event to connect community physicians, patients, and advocates with academic researchers and industry leaders. Our vision is to provide an educational forum to raise awareness about advances in breast cancer research, treatment, and testing.


  • Archer at Immunology 2017
    May 12, 2017

    Archer exhibits at the American Association of Immunologists Annual Meeting–Immunology 2017 in Washington, DC. At the largest annual gathering of immunologists worldwide, scientists discuss breakthroughs across the full spectrum of topics in the Immunology.


  • More News


Archer kits find genetic mutations with NGS

Archer's proprietary target-enrichment chemistry and software work together to provide highly confident mutation calls.

For Research Use Only. Not for use in diagnostic procedures.For Research Use Only. Not for use in diagnostic procedures.


Fusions

Gene Fusions and Translocations

Gene fusions can occur as a result of chromosomal inversions, interstitial deletions, or translocations in the genome. Gene fusions can drive cancer development and progression, making them important therapeutic targets. Archer technology is purpose-built for accurate, powerful and scalable gene fusion detection with next generation sequencing.

Detected in the following assays:

Archer FusionPlex
RNA assays
CNVs

Copy Number Variations (CNVs)

Copy number variation (CNV) is a common form of structural genomic aberration in which large regions of the genome are deleted or duplicated. Constitutional and somatic CNVs are associated with a wide variety of cancers and represent an important area of research. Archer technology enables highly-multiplexed, quantitative assessment of genomic regions through next generation sequencing.

Detected in the following assays:

Archer VariantPlex
DNA assays
Indels

Insertions/Deletions (indels)

Insertions and deletions (indels) are mutations of the genome resulting from the omission or addition of nucleotides into a sequence of DNA. Indels can alter amino acid coding sequence and cause detrimental cellular effects. Archer technology is uniquely suited for indel detection due to novel chemistry and powerful next generation sequencing analysis.

SNVs/SNPs

Single Nucleotide Variants/Polymorphisms (SNVs, SNPs)

Point mutations, single nucleotide variants (SNV) or single base substitutions of the genome can have various implications on cellular function and can cause or lead to diseases of the genome – like cancer. Archer technology enables the precise targeting of the genome for nucleotide-level detection of point mutations with next generation sequencing.

Expression

RNA Gene Expression

Gene expression is a measure of functional RNA that can provide critical insights into cellular origin and regulation. The molecular signatures gathered from RNA abundance can assist in classification of tumor types. The quantitative nature of Archer technology allows for measuring relative RNA abundance so researchers can get more information from next generation sequencing.

Detected in the following assays:

Archer FusionPlex
RNA assays

How to contact us

Address

2477 55th Street, Suite 202

Boulder, CO 80301

Phone

Phone: (877) 771 1093

Phone: (303) 357 9001

All content © 2017 ArcherDX, Inc.

For Research Use Only. Not for use in diagnostic procedures. For Research Use Only. Not for use in diagnostic procedures.